Inventor
WANG TIE-LIN
US26 patents
⚠️ This page may combine multiple inventors who share the name “WANG TIE-LIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
LUOXIN PHARMACEUTICAL SHANGHAI CO LTD
5 patentsUS10519143B2Dec 31, 2019
Substituted-indole-compounds as estrogen receptor down-regulators
LUOXIN PHARMACEUTICAL SHANGHAI CO LTD3 citations70
US11034653B2Jun 15, 2021
Crystal form of estrogen receptor inhibitor and preparation method therefor
LUOXIN PHARMACEUTICAL SHANGHAI CO LTD2 citations67
US12098127B2Sep 24, 2024
Salt form of estrogen receptor downregulator, crystalline form thereof, and preparation method therefor
LUOXIN PHARMACEUTICAL SHANGHAI CO LTD0 citations58
US10774081B2Sep 15, 2020
Indolo substituted piperidine compound as estrogen receptor down-regulator
LUOXIN PHARMACEUTICAL SHANGHAI CO LTD0 citations49
US11639355B2May 2, 2023
Substituted pyrrolo[3,4-d]imidazoles as MDM2-p53 inhibitors
LUOXIN PHARMACEUTICAL SHANGHAI CO LTD0 citations45
EXELIXIS INC
4 patentsUS7595311B2Sep 29, 2009
Azepinoindole derivatives as pharmaceutical agents
EXELIXIS INC29 citations91
US7485634B2Feb 3, 2009
Azepinoindole and pyridoindole derivatives as pharmaceutical agents
EXELIXIS INC49 citations91
US8026237B2Sep 27, 2011
Pyrrole derivatives as pharmaceutical agents
EXELIXIS INC4 citations61
US8367667B2Feb 5, 2013
Pyrrole derivatives as pharmaceutical agents
EXELIXIS INC1 citations50